J&J Beats MDL Over Defective Children's Drugs

Law360, New York (July 16, 2012, 4:54 PM EDT) -- A federal judge on Friday threw out multidistrict litigation alleging Johnson & Johnson's McNeil Consumer Healthcare division hid defects from the public regarding children’s Tylenol and other children's drugs, ruling all 24 named plaintiffs in the litigation lacked standing to sue.

The plaintiffs had contended that they paid an inflated price for the drugs they purchased after there had been quality control problems at Johnson & Johnson’s facility manufacturing over-the-counter medications in Fort Washington, Pa. But U.S. District Judge Mary McLaughlin dismissed all claims with prejudice,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.